Latest News & Features
Americas
Law firm Paul Hastings announced yesterday that Chad Peterman has joined the firm as a partner in the IP practice based in New York. 19 July 2016
Americas
A committee at the US Food and Drug Administration has approved a biosimilar application by pharmaceutical company Sandoz. 18 July 2016
Americas
US drugs company Pfizer has entered into a manufacturing and licensing agreement with Russian pharmaceutical company NovaMedica. 18 July 2016
Americas
Biotechnology company Amgen and Japan-based Daiichi Sankyo have agreed a deal that will allow for the commercialisation of nine biosimilars in Japan. 15 July 2016
Americas
Illumina has reached a settlement with Enzo Life Sciences, bringing an end to allegations that it infringed a DNA detection patent. 14 July 2016
Americas
US biopharmaceutical company Spectrum Pharmaceuticals announced yesterday that it had reached a settlement with UK healthcare company Fresenius Kabi in a patent dispute centring on the drug Folotyn. 14 July 2016
Big Pharma
For many of the key questions relating to the grant of SPCs, there is some variance in the practice of national patent offices, even where there is guidance from the CJEU, as Simon Spink and Adrian Chew of Bristows explain. 14 July 2016
Asia-Pacific
Several legislative changes affecting data exclusivity of biologic drugs in Vietnam are poised to come into effect, and companies operating in this sector should take note now, as Hien Thi Thu Vu and Huong Lan Nguyen of Tilleke & Gibbins explain. 14 July 2016
Americas
A US court has sided with Forest Laboratories in a dispute with Mylan Pharmaceuticals centring on the Savella drug. 13 July 2016
Americas
AstraZeneca announced today that it has entered into an agreement with Sandoz to resolve patent litigation between the two companies. 13 July 2016